Verteporfin

Drugs and Aging

Volumn 16, Issue 2, 2000, Pages 139-146

  Scott, Lesley J ^a   Goa, Karen L ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; LOW DENSITY LIPOPROTEIN RECEPTOR; OXYGEN RADICAL; PHOTOSENSITIZING AGENT;

BACKACHE; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG UPTAKE; HUMAN; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TARGET CELL; THROMBUS; VISUAL ACUITY; VISUAL DISORDER;

EID: 0034050906     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200016020-00005     Document Type: Review

References (22)

1. 1. Klein R, Klein B, Linton K. Prevalence of age-related maculopathy. Ophthalmology 1992; 99: 933-43
2. 2. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996 Mar; 103: 427-38
3. 3. Husain D, Miller JW. Photodynamic therapy of exudative age-related macular degeneration. Semin Ophthalmol 1997; 12 (1): 14-25
4. 4. Schmidt-Erfurth U, Birngruber R, Hasah T. Photodynamic therapy in ocular vascular disease. Laser Physics 1998; 8: 191-8
5. 5. Fine SELL. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration. Arch Ophthalmol 1999; 117: 1400-2
6. 6. Levy JG. Photosensitizes in photodynamic therapy. Semin Oncol 1994 Dec; 21 Suppl. 15: 4-10
7. 7. Richter AM, Waterfield E, Jain AK, et al. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem Photobiol 1990 Sep; 52: 495-500
8. 8. Richter A, Sternberg E. Waterfield E, et al. Characterisation of benzoporphyrin derivative, a new photosensitiser. Adv Photochemother 1988; 997: 132-8
9. 9. Richter AM, Waterfield E, Jain AK. et al. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br J Cancer 1991 Jan; 63: 87-93
10. 10. Allison B A, Pritchard PH, Levy JG. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative [published erratum appears in Br J Cancer 1995 Jan; 71 (1): 214]. Br J Cancer 1994 May; 69: 833-9
11. 11. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995 Jun; 113: 810-8
12. 12. Husain D, Miller JW, Michaud N, et al. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996 Aug; 114: 978-85
13. 13. Schmidt-Erfurth U, Hasan T, Gragoudas E, et al. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994 Dec; 101: 1953-61
14. 14. Lin SC, Lin CP, Feld JR, et al. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res 1994 Jul: 13: 513-22
15. 15. Reinke MH, Canakis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in cynomolgus monkey. Ophthalmology 1999; 106: 1915-23
16. 16. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998 May; 236: 365-74
17. 17. Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularisation by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1161-73
18. 18. Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularisation caused by age-related macular degeneration: results of retreatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1177-87
19. 19. Allison BA, Pritchard PH, Richter AM, et al. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution. Photochem Photobiol 1990 Sep; 52: 501-7
20. 20. Richter AM, Waterfield E, Jain AK, et al. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumour tissue in a mouse tumour model. Photochem Photobiol 1993 Jun; 57: 1000-6
21. 21. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with veneporfin. Arch Ophthalmol 1999; 117: 1329-45
22. 22. Ciba Vision. Regulatory submissions. Viewpoint 1999 (News on the developments in photodynamic therapy): 3